Thanks @shax786 - I would defer to the more scientific posters like @otherperspective and @LeftYahoo on their opinions
There are risks, but I'd look at the following to gain a level of confidence:...
- We did not make a new product, specifically for Covid-19. We've been working on Rem-L for a long time, it just happens that it also works well for Covid-19 ARDS
- SI & team - would not risk damaging Mesoblast suite of products at the 11th hour to pivot for ARDS, if he didn't have sufficient data
- Rem-L is safe and effective; as demonstrated in ODAC and Japan
- EAP success
- NIH willing to back Mesoblast (to the tune of US$50m or so)
- All these hospitals signing up
- The doctors, who have been interviewed have nothing but praises
However, there are two main risks for me with Covid-19 ARDS:
- 90 patients is not enough patients for DSMB to call off the trial due to overwhelming success. My concern here is not the % of success, but rather the 45 patients being treated on Rem-L is not enough. But, hey these are legit numbers that the FDA as agreed to - so who knows
- Manufacturing - Mesoblast has been dealing with a niche market for aGVHD and are not ready for the massive massive lift in volume to deal with Covid-19 ARDS. The last CR was specifically raised to deal with this, but it all takes time. If the FDA had concerns with manufacturing for a niche aGVHD market, what concerns would they have with Covid-19 ARDS. So, with pressure from the WH some manufacturing news/ partnership is required here - FDA themselves need to step up and allow an accelerated path for 3D
- Forums
- ASX - By Stock
- MSB
- MSB - Most exciting 6 months
MSB
mesoblast limited
Add to My Watchlist
1.55%
!
$1.59

MSB - Most exciting 6 months, page-619
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.59 |
Change
-0.025(1.55%) |
Mkt cap ! $2.031B |
Open | High | Low | Value | Volume |
$1.61 | $1.62 | $1.57 | $6.345M | 3.987M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 44493 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 4159 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 44493 | 1.585 |
11 | 152673 | 1.580 |
11 | 113158 | 1.575 |
21 | 148384 | 1.570 |
3 | 78851 | 1.565 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 4159 | 1 |
1.595 | 17500 | 2 |
1.600 | 48600 | 4 |
1.605 | 38500 | 3 |
1.610 | 5000 | 1 |
Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |